However, high PTX3 levels were associated with a more aggressive disease, as indicated by tumour stage and the development of metastatic disease, and thus circulating PTX3 levels could be a potential biomarker for prognostication of BC. The gene discussed is PTX3; the disease is metastatic neoplasm.